Scientific Meeting for Cardiologists — Forxiga & AstraZeneca

📸 A look back at a scientific meeting bringing together cardiologists at Polyclinique Cardiologique de Nabeul. 🩺 Particular attention was given to Forxiga, an innovative treatment developed by AstraZeneca, notably for the management of heart failure and diabetes, sparking in-depth scientific discussion and the sharing of clinical experience among colleagues. In a friendly and professional atmosphere, this meeting helped strengthen medical collaboration and reinforce a shared vision focused on excellence in care ❤️‍🩺 🥐 This special moment was also accompanied by a pleasant breakfast offered by AstraZeneca laboratories, whom we warmly thank. 👏 Together, let's keep advancing cardiology for the benefit of our patients.